Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 5/20 | 0.70 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.70 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | LDHA | P00338 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL1025498 | 1.00 | — | — | |
| Oxalic Acid SCHEMBL201067 | 0.94 | — | — | |
| Oxalic Acid SCHEMBL15940835 | 0.89 | CA4 (0.70) | CA4FAHD1MEN1LDHABLM | |
| Oxalic Acid SCHEMBL10354524 | 0.89 | CA4 (0.70) | CA4FAHD1MEN1LDHABLM | |
| Oxalic Acid SCHEMBL1635571 | 0.89 | CA4 (0.70) | CA4FAHD1MEN1LDHABLM | |
| Oxalic Acid SCHEMBL12274005 | 0.89 | CA4 (0.70) | CA4FAHD1MEN1LDHABLM | |
| Oxalic Acid SCHEMBL5807089 | 0.89 | — | — | |
| Oxalic Acid SCHEMBL9879794 | 0.88 | CA4 (0.88) | CA4FAHD1MEN1LDHABLM | |
| Oxalic Acid SCHEMBL50017 | 0.88 | — | — | |
| Oxalic Acid SCHEMBL6018199 | 0.88 | CA4 (0.88) | CA4FAHD1MEN1LDHABLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11612881-B2 | Process for preparing an epoxidation catalyst | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2023-03-28 | — | — | US | disclosed |
| US-20210178367-A1 | PROCESS FOR PREPARING AN EPOXIDATION CATALYST | DOW TECHNOLOGY INVESTMENTS LLC | 2021-06-17 | — | — | US | disclosed |
| EP-3731963-A1 | PROCESS FOR PREPARING AN EPOXIDATION CATALYST | Dow Technology Investments LLC (US) | 2020-11-04 | — | — | EP | disclosed |
| US-10821430-B2 | Process for preparing an epoxidation catalyst | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2020-11-03 | — | — | US | disclosed |
| CN-111556786-A | Process for preparing epoxidation catalyst | 陶氏技术投资有限责任公司 | 2020-08-18 | — | — | CN | disclosed |
| EP-3507010-A1 | PROCESS FOR PREPARING AN EPOXIDATION CATALYST | Dow Technology Investments LLC (US) | 2019-07-10 | — | — | EP | disclosed |
| US-20190184387-A1 | PROCESS FOR PREPARING AN EPOXIDATION CATALYST | THE DOW CHEMICAL COMPANY | 2019-06-20 | — | — | US | disclosed |
| WO-2018044982-A1 | PROCESS FOR PREPARING AN EPOXIDATION CATALYST | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2018-03-08 | — | — | WO | disclosed |
| US-9908861-B2 | Method of formulating alkylene oxide catalyst in relation to catalyst reference properties | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2018-03-06 | — | — | US | disclosed |
| US-20170217915-A1 | METHOD OF FORMULATING ALKYLENE OXIDE CATALYST IN RELATION TO CATALYST REFERENCE PROPERTIES | DOW TECHNOLOGY INVESTMENTS LLC | 2017-08-03 | — | — | US | disclosed |
| WO-2001044219-A1 | GAS PHASE EPOXIDATION OF NON-ALLYLIC OLEFINS | EASTMAN CHEMICAL COMPANY (US) | 2001-06-21 | — | — | WO | disclosed |
| US-6172245-B1 | USING NITROGEN BASIC COMPOUND AND SILVER CATALYST ON SUPPORT | EASTMAN CHEMICAL COMPANY | 2001-01-09 | — | — | US | disclosed |
| EP-0722444-B1 | GAS PHASE PROCESS FOR THE EPOXIDATION OF NON-ALLYLIC OLEFINS | EASTMAN CHEM CO (US) | 1997-05-28 | — | — | EP | disclosed |
| EP-0641332-B1 | EPOXIDATION USING THALLIUM PROMOTED SILVER CATALYSTS | EASTMAN CHEM CO (US) | 1997-02-05 | — | — | EP | disclosed |
| EP-0722444-A1 | GAS PHASE PROCESS FOR THE EPOXIDATION OF NON-ALLYLIC OLEFINS | EASTMAN CHEM CO (US) | 1996-07-24 | — | — | EP | disclosed |
| WO-1995009850-A1 | GAS PHASE PROCESS FOR THE EPOXIDATION OF NON-ALLYLIC OLEFINS | EASTMAN CHEMICAL COMPANY (US) | 1995-04-13 | — | — | WO | disclosed |
| EP-0641332-A1 | EPOXIDATION USING THALLIUM PROMOTED SILVER CATALYSTS. | EASTMAN CHEM CO (US) | 1995-03-08 | — | — | EP | disclosed |
| US-5362890-A | Silver catalyst, in paraffin diluent with high heat capacity to help remove heat from the exothermic reaction | EASTMAN CHEMICAL COMPANY (US) | 1994-11-08 | — | — | US | disclosed |
| WO-1993003024-A1 | EPOXIDATION USING THALLIUM PROMOTED SILVER CATALYSTS | EASTMAN CHEMICAL COMPANY (US) | 1993-02-18 | — | — | WO | disclosed |
| US-5138077-A | Using thallium-promoted, silver catalyst | EASTMAN KODAK COMPANY (US) | 1992-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170217915-A1 | METHOD OF FORMULATING ALKYLENE OXIDE CATALYST IN RELATION TO CATALYST REFERENCE PROPERTIES | HMOX2, DNMT1, RIOX2 | CA4 3342/4885FAHD1 4722/4885MEN1 995/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.